Stavanger Universitetssykehus

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Insomnia1 trial
• Ovarian cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Helse Møre og Romsdal HF1 trial
• Helse Stavanger HF1 trial
• Oslo University Hospital1 trial
• St. Olavs Hospital1 trial

Running trials

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Eli Lilly and Company· Source

  Contact: Elisabeth Nilsen (principal investigator)

• Recruiting

  Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial

  NCT07145307· Helse Stavanger HF· Source

  Contact: Pia R Hauge, Master

• Recruiting

  Improving Public Cancer Care by Implementing Precision Medicine in Norway

  NCT04817956· Phase 2· Oslo University Hospital· Source

  Contact: Bjørnar Gilje

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Completed

  Digital Cognitive Behavior Therapy for Insomnia Compared With Digital Patient Education About Insomnia in Individuals Referred to Public Mental Health Services in Norway

  NCT04621643· St. Olavs Hospital· Source

• Completed

  Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?

  NCT03011268· Helse Møre og Romsdal HF· Source